Presence of mutation in genes associated with epigenetic regulation confer poor long-term TKI response. Barplots comparing percentage of patients that successfully achieve 3 treatment response milestones (1 per barplot) in patients that had mutations in genes associated with epigenetic regulation (DNA methylation and chromatin modifiers) vs all other patients.